CN101766841A - Artificial joint having slow-release function of rare earth element cerium and preparation method thereof - Google Patents
Artificial joint having slow-release function of rare earth element cerium and preparation method thereof Download PDFInfo
- Publication number
- CN101766841A CN101766841A CN201010017102A CN201010017102A CN101766841A CN 101766841 A CN101766841 A CN 101766841A CN 201010017102 A CN201010017102 A CN 201010017102A CN 201010017102 A CN201010017102 A CN 201010017102A CN 101766841 A CN101766841 A CN 101766841A
- Authority
- CN
- China
- Prior art keywords
- cerium
- artificial joint
- sodium titanate
- rare earth
- earth element
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052684 Cerium Inorganic materials 0.000 title claims abstract description 45
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 229910052761 rare earth metal Inorganic materials 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- GROMGGTZECPEKN-UHFFFAOYSA-N sodium metatitanate Chemical compound [Na+].[Na+].[O-][Ti](=O)O[Ti](=O)O[Ti]([O-])=O GROMGGTZECPEKN-UHFFFAOYSA-N 0.000 claims abstract description 58
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 48
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims abstract description 39
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims abstract description 39
- 229940112869 bone morphogenetic protein Drugs 0.000 claims abstract description 39
- 230000000975 bioactive effect Effects 0.000 claims abstract description 28
- 238000000576 coating method Methods 0.000 claims abstract description 20
- 239000011248 coating agent Substances 0.000 claims abstract description 19
- 238000005516 engineering process Methods 0.000 claims abstract description 19
- 238000001027 hydrothermal synthesis Methods 0.000 claims abstract description 17
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000011068 loading method Methods 0.000 claims abstract description 12
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 12
- 239000010936 titanium Substances 0.000 claims abstract description 12
- 238000005342 ion exchange Methods 0.000 claims abstract description 11
- 229910052751 metal Inorganic materials 0.000 claims abstract description 11
- 239000002184 metal Substances 0.000 claims abstract description 11
- 229910001069 Ti alloy Inorganic materials 0.000 claims abstract description 9
- 239000011159 matrix material Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 23
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 150000000703 Cerium Chemical class 0.000 claims description 13
- 230000004071 biological effect Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000005470 impregnation Methods 0.000 claims description 7
- 150000002500 ions Chemical class 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 6
- 239000002953 phosphate buffered saline Substances 0.000 claims description 6
- 239000012266 salt solution Substances 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 5
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 claims description 4
- 150000002910 rare earth metals Chemical class 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- HKVFISRIUUGTIB-UHFFFAOYSA-O azanium;cerium;nitrate Chemical compound [NH4+].[Ce].[O-][N+]([O-])=O HKVFISRIUUGTIB-UHFFFAOYSA-O 0.000 claims description 2
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 238000005498 polishing Methods 0.000 claims description 2
- 238000013268 sustained release Methods 0.000 claims 3
- 239000012730 sustained-release form Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000011734 sodium Substances 0.000 abstract description 2
- 229910052708 sodium Inorganic materials 0.000 abstract description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 5
- 230000011164 ossification Effects 0.000 description 5
- 229910000667 (NH4)2Ce(NO3)6 Inorganic materials 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000010335 hydrothermal treatment Methods 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000002344 surface layer Substances 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 229910052586 apatite Inorganic materials 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 229910000883 Ti6Al4V Inorganic materials 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229910003089 Ti–OH Inorganic materials 0.000 description 1
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical group [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- -1 sodium cations Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Landscapes
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明是一种稀土元素铈缓释功能性的人工关节及其制备方法,这种人工关节由纯钛或钛合金人工关节基体以及负载有稀土元素铈和骨形态发生蛋白(BMP)的微孔钛酸钠生物活性层组成。所述及的具有微孔结构的钛酸钠层生物活性层与金属基体表面结合,由钛或者钛合金基体表面与氢氧化钠溶液水热反应生成的钛酸钠微孔结构相互交替堆叠而成,铈与钠进行阳离子交换掺入涂层,BMP通过离心力与毛细管作用复合于微孔结构中。制备的方法为:首先选用纯钛或钛合金加工好人工关节;然后采用碱液水热合成技术在人工关节表面获得具有微孔结构的钛酸钠层;再通过溶液浸渍离子交换在微孔钛酸钠层内掺入稀土元素铈;最后采用离心负载技术在掺铈的微孔钛酸钠层内负载骨形态发生蛋白。
The invention relates to an artificial joint with slow-release function of rare earth element cerium and a preparation method thereof. The artificial joint is composed of pure titanium or titanium alloy artificial joint matrix and micropores loaded with rare earth element cerium and bone morphogenetic protein (BMP). Sodium titanate bioactive layer composition. The aforementioned bioactive layer of sodium titanate layer with a microporous structure is combined with the surface of the metal substrate, and the microporous structure of sodium titanate formed by the hydrothermal reaction of the surface of the titanium or titanium alloy substrate and the sodium hydroxide solution is stacked alternately. , Cerium and sodium are cation-exchanged and incorporated into the coating, and BMP is compounded in the microporous structure through centrifugal force and capillary action. The preparation method is as follows: first select pure titanium or titanium alloy to process the artificial joint; then use lye hydrothermal synthesis technology to obtain a sodium titanate layer with a microporous structure on the surface of the artificial joint; then impregnate the ion exchange on the microporous titanium The rare earth element cerium was mixed into the sodium titanate layer; finally, the bone morphogenetic protein was loaded in the microporous sodium titanate layer doped with cerium by centrifugal loading technology.
Description
技术领域technical field
本发明涉及一种稀土元素铈缓释功能性的人工关节及其制备方法,特别涉及一种选用纯钛或钛合金加工基体,采用碱液水热合成技术获得微孔钛酸钠生物活性涂层,通过溶液浸渍离子交换掺铈,使用离心负载技术负载骨形态发生蛋白的人工关节及其制备方法,属于人工关节材料技术领域。The present invention relates to an artificial joint with slow-release function of rare earth element cerium and its preparation method, in particular to a microporous sodium titanate bioactive coating obtained by selecting pure titanium or titanium alloy as a substrate and adopting lye hydrothermal synthesis technology The invention relates to an artificial joint loaded with bone morphogenetic protein through solution impregnation ion exchange doped with cerium and using a centrifugal loading technique and a preparation method thereof, belonging to the technical field of artificial joint materials.
背景技术Background technique
目前,人工关节植入人体的病例数量每年可达120万例,是国内外骨科需求量最大的植入材料之一。通常使用的人工关节是金属材料,因其是生物惰性材料,与人体骨组织之间不能形成牢固的生理结合,在植入几年后,常常会发生松动、下沉,导致人工关节置换失败,二次手术不可避免。采用表面改性技术在人工关节金属基体表面制备生物涂层(膜),可降低人体环境下有害金属离子的溶出,提高其生物相容性和生物活性,使得人工关节与人体骨组织之间形成牢固的生理结合。At present, the number of cases of artificial joint implanted into the human body can reach 1.2 million cases per year, and it is one of the implant materials with the largest demand in orthopedics at home and abroad. The commonly used artificial joints are metal materials. Because they are biologically inert materials, they cannot form a firm physiological bond with human bone tissue. After several years of implantation, they often loosen and sink, resulting in failure of artificial joint replacement. Second surgery is inevitable. Using surface modification technology to prepare biological coatings (films) on the surface of artificial joint metal substrates can reduce the dissolution of harmful metal ions in the human environment, improve their biocompatibility and biological activity, and make the artificial joints and human bone tissue form Strong physical bond.
稀土元素铈有良好的物理化学稳定性,可以通过高温、高压以及滤过等方法进行灭菌。铈元素具有多种生物学效应:高浓度的铈通过软化细胞壁将其分离,并逐步使原生质溢出,进而达到抑制细菌生长的目的;它还可能会固定烧伤时产生的脂蛋白混合物,阻止其进入体内,从而减轻炎性反应,并能防止烧伤后的免疫抑制现象,使组织受到的损伤不会进一步加重;可通过促进DNA无误修复和阻断致突变物对正常DNA损伤等方式来达到抗突变作用。The rare earth element cerium has good physical and chemical stability, and can be sterilized by high temperature, high pressure and filtration. Cerium has a variety of biological effects: high concentrations of cerium separate it by softening the cell wall, and gradually cause the protoplasm to overflow, thereby achieving the purpose of inhibiting bacterial growth; it may also fix the lipoprotein mixture produced during burns and prevent it from entering In vivo, so as to reduce the inflammatory reaction and prevent the immunosuppressive phenomenon after burns, so that the damage to the tissue will not be further aggravated; it can achieve anti-mutation by promoting the correct DNA repair and blocking the normal DNA damage caused by the mutagen effect.
骨形态发生蛋白(BMP)是广泛存在于骨基质中的一种低分子糖蛋白多肽,可以作用于间充质细胞表面受体,诱导血管周围的未分化间充质细胞和骨髓基质细胞转化为软骨和骨细胞,具有诱导骨形成的生物特性。在人工关节表面负载骨形态发生蛋白(BMP),可以显著提高植入初期人工关节表面诱导成骨的能力。但是BMP易被较快吸收、降解,必须要有合适的载体起到提高其释放周期的作用。Bone morphogenetic protein (BMP) is a low-molecular-weight glycoprotein polypeptide widely present in the bone matrix, which can act on the surface receptors of mesenchymal cells and induce the transformation of undifferentiated mesenchymal cells around blood vessels and bone marrow stromal cells into Cartilage and bone cells with biological properties that induce bone formation. Loading bone morphogenetic protein (BMP) on the surface of the artificial joint can significantly improve the ability of the surface of the artificial joint to induce osteogenesis at the initial stage of implantation. However, BMP is easily absorbed and degraded quickly, and a suitable carrier must be provided to improve its release cycle.
人体硬组织的主要无机质是钙磷相,而钛酸钠盐在体液中可以转变为水合二氧化钛,使金属表面原位形成许多Ti-OH基团,从而诱导体液中的钙、磷沉积,形成磷灰石层(Ceramics International,1996,79(24):1127-1129)。另外由于钛酸钠晶体的特殊结构,使得钠离子有着很强的交换能力,可以与多种阳离子进行置换,从而进行离子缓释,加强钛酸钠结构层的功能性。同时表面微孔的特殊形貌增大了比表面积,使得钛酸钠结构层在负载能力方面得到极大的增强。The main inorganic substance of human hard tissue is calcium-phosphorus phase, and sodium titanate can be converted into hydrated titanium dioxide in body fluids, so that many Ti-OH groups are formed on the metal surface in situ, thereby inducing the deposition of calcium and phosphorus in body fluids, forming Apatite layers (Ceramics International, 1996, 79(24): 1127-1129). In addition, due to the special structure of sodium titanate crystals, sodium ions have a strong exchange capacity, which can be replaced with a variety of cations, so as to perform ion release and strengthen the functionality of the sodium titanate structural layer. At the same time, the special morphology of the micropores on the surface increases the specific surface area, which greatly enhances the loading capacity of the sodium titanate structure layer.
制备具有生物活性的钛酸钠结构的常用方法是碱液水热合成技术。中国专利ZL02117866.6“一种制备水合钛酸钠盐以及系列钛酸盐纳米管的工艺方法”公开了一种基于碱液水热合成技术制备钛酸钠纳米结构的方法,即在密闭容器中使用二氧化钛粉体或者偏钛酸粉体与氢氧化钠溶液进行水热反应,最终制得具有管状结构的分散的钛酸钠盐。但该制备方法只能制备出分散的钛酸盐结构,并没有涉及金属基体表面的制备。而钛酸钠作为一种极具潜力的生物医用材料,还很少有应用于人工关节材料技术领域。因此寻找合适的工艺在人工关节金属基体表面制备具有特殊结构的钛酸钠生物活性涂层,并且增强其功能性和负载能力,将越来越受到人工关节材料技术领域的重视。A common method for preparing biologically active sodium titanate structures is lye hydrothermal synthesis technology. Chinese patent ZL02117866.6 "A process for preparing hydrated sodium titanate and a series of titanate nanotubes" discloses a method for preparing sodium titanate nanostructures based on lye hydrothermal synthesis technology, that is, in a closed container Titanium dioxide powder or metatitanic acid powder is used for hydrothermal reaction with sodium hydroxide solution to finally prepare dispersed sodium titanate salt with tubular structure. However, this preparation method can only prepare dispersed titanate structures, and does not involve the preparation of the surface of the metal substrate. As a biomedical material with great potential, sodium titanate is rarely used in the technical field of artificial joint materials. Therefore, looking for a suitable process to prepare a sodium titanate bioactive coating with a special structure on the surface of the artificial joint metal substrate, and to enhance its functionality and load capacity will be more and more valued by the technical field of artificial joint materials.
发明内容Contents of the invention
技术问题:本发明的目的是针对人工关节材料上述不足,提出一种具有稀土元素铈缓释功能,并且可以显著提高植入初期人工关节表面诱导成骨能力的人工关节及其制备方法。Technical problem: The purpose of the present invention is to address the above-mentioned shortcomings of artificial joint materials, and propose an artificial joint with a slow-release function of rare earth element cerium, and can significantly improve the ability of the artificial joint surface to induce osteogenesis at the initial stage of implantation and its preparation method.
技术方案:这种稀土元素铈缓释功能性的人工关节在金属基体表面有一层采用碱液水热合成技术制备的具有微孔结构的钛酸钠生物活性层,其表面利用溶液浸渍离子交换进行掺铈,并且使用离心负载技术复合有骨形态发生蛋白(BMP)。具有微孔结构的钛酸钠生物活性层与金属基体结合强度高,由于钛酸钠微孔结构交替堆叠生长于基体表面,具有很好的生物活性并且能促进磷灰石层的沉积生长;铈元素掺入后在人工关节表面缓释,具有多种生物学效应,可以产生抑制细菌的生长、减轻炎性反应等有益效果。同时微孔结构也是BMP的理想载体。人工关节与BMP复合通常采用离心负载技术,BMP可通过离心效应与毛细管效应的双重作用深入渗透到微孔钛酸钠涂层中,使人工关节表面BMP的携带量大大提高。人工关节植入人体后,其表面BMP释放周期延长,有利于BMP诱导成骨作用的充分发挥。Technical solution: The artificial joint with rare earth element cerium slow-release function has a layer of sodium titanate bioactive layer with microporous structure prepared by lye hydrothermal synthesis technology on the surface of the metal substrate, and its surface is treated by ion exchange by solution impregnation. Doped with cerium and complexed with bone morphogenetic protein (BMP) using centrifugal loading technology. The sodium titanate bioactive layer with a microporous structure has high bonding strength to the metal substrate. Since the microporous structure of sodium titanate alternately stacks and grows on the surface of the substrate, it has good biological activity and can promote the deposition and growth of the apatite layer; cerium After the elements are incorporated, they are released slowly on the surface of the artificial joint, which has a variety of biological effects, and can produce beneficial effects such as inhibiting the growth of bacteria and reducing inflammatory reactions. At the same time, the microporous structure is also an ideal carrier for BMP. Artificial joints and BMP composites usually use centrifugal loading technology. BMP can penetrate deeply into the microporous sodium titanate coating through the dual effects of centrifugal effect and capillary effect, which greatly increases the carrying capacity of BMP on the surface of artificial joints. After the artificial joint is implanted in the human body, the release cycle of BMP on its surface is prolonged, which is conducive to the full play of BMP-induced osteogenesis.
本发明通过以下技术方案加以实现:The present invention is realized through the following technical solutions:
在这种稀土元素铈缓释功能性的人工关节金属基体表面有一层具有微孔结构的钛酸钠生物活性涂层,微孔涂层上进一步掺铈,并且复合有骨形态发生蛋白(BMP)。There is a layer of sodium titanate bioactive coating with a microporous structure on the surface of the artificial joint metal substrate with slow-release function of rare earth element cerium. The microporous coating is further doped with cerium and compounded with bone morphogenetic protein (BMP). .
所述及的微孔结构的钛酸钠生物活性涂层与金属基体表面结合,由钛或者钛合金基体表面与氢氧化钠溶液进行水热反应生成的钛酸钠微孔结构相互交替堆叠而成;所述及的铈元素通过溶液浸渍与钛酸钠的钠离子进行阳离子交换;所述及的BMP由离心负载技术复合于微孔结构涂层中。The microporous structure of the sodium titanate bioactive coating is combined with the surface of the metal substrate, and the sodium titanate microporous structure formed by the hydrothermal reaction between the surface of the titanium or titanium alloy substrate and the sodium hydroxide solution is stacked alternately. The mentioned cerium element is cation-exchanged with the sodium ion of sodium titanate through solution impregnation; the mentioned BMP is compounded in the microporous structure coating by centrifugal loading technology.
其制备的步骤如下:Its preparation steps are as follows:
1)首先选用纯钛或者钛合金加工好人工关节;1) First choose pure titanium or titanium alloy to process the artificial joint;
2)把人工关节表面打磨抛光,然后采用碱液水热合成技术在其表面获得具微孔结构的钛酸钠生物活性涂层;2) Grinding and polishing the surface of the artificial joint, and then using lye hydrothermal synthesis technology to obtain a sodium titanate bioactive coating with a microporous structure on the surface;
3)再通过溶液浸渍离子交换在微孔钛酸钠层内掺入稀土元素铈;3) doping the rare earth element cerium in the microporous sodium titanate layer through solution impregnation ion exchange;
4)最后采用离心负载技术在掺铈的微孔钛酸钠层内负载骨形态发生蛋白。4) Finally, the bone morphogenetic protein is loaded in the microporous sodium titanate layer doped with cerium by centrifugal loading technology.
所述及的碱液水热合成技术,采用浓度为5~15mol/L的NaOH水溶液,处理时间为4~200小时,处理温度为60~180摄氏度。The lye hydrothermal synthesis technology mentioned above uses NaOH aqueous solution with a concentration of 5-15 mol/L, the treatment time is 4-200 hours, and the treatment temperature is 60-180 degrees Celsius.
所述及的溶液浸渍离子交换,采用浓度为0.05-5.0mol·L-1可溶性铈盐水溶液,可溶性铈盐水溶液液面应淹过人工关节,浸渍时间不少于24小时,随后用去离子水清洗几次,以消除剩余的可溶性离子,样品在真空下60-100℃干燥不少于6小时;所述的可溶性铈盐水溶液采用硝酸铈、硝酸铈氨或氯化铈中的一种或两种可溶性铈盐配制。The above-mentioned solution is impregnated with ion exchange, using a soluble cerium salt solution with a concentration of 0.05-5.0mol L -1 , the liquid surface of the soluble cerium salt solution should be submerged over the artificial joint, the immersion time is not less than 24 hours, and then deionized water Wash several times to eliminate remaining soluble ions, and dry the sample at 60-100°C under vacuum for no less than 6 hours; the soluble cerium salt solution uses one or both of cerium nitrate, cerium nitrate ammonium or cerium chloride A soluble cerium salt preparation.
所述及的离心负载技术具体操作为:将表面具有掺铈微孔钛酸钠生物活性涂层的人工关节置于离心机中,倒入浓度为0.1~50mg/L的骨形态发生蛋白和0.1mol/L的磷酸缓冲盐溶液组成的混合溶液,并淹过两倍以上高度,以2000~80000rpm的离心速度工作5~30min,其间保持工作温度为4~40℃。The specific operation of the centrifugal loading technology mentioned is as follows: the artificial joint with the bioactive coating of cerium-doped microporous sodium titanate on the surface is placed in a centrifuge, and the concentration of 0.1-50 mg/L bone morphogenetic protein and 0.1 mol/L phosphate-buffered saline solution, and submerged to more than twice the height, and worked at a centrifugal speed of 2000-80000rpm for 5-30min, during which the working temperature was kept at 4-40°C.
有益效果:Beneficial effect:
(1)铈元素具有多种生物学效应,向人工关节表面微孔钛酸钠生物活性层中掺铈,可以产生抑制细菌的生长、减轻炎性反应等有益效果。该人工关节材料有很好的生物活性、杀菌作用以及诱导成骨效应,可在短期内安全地与骨组织形成牢固的生理结合。(1) The cerium element has various biological effects. Doping cerium into the microporous sodium titanate bioactive layer on the surface of the artificial joint can produce beneficial effects such as inhibiting the growth of bacteria and reducing inflammatory reactions. The artificial joint material has good biological activity, bactericidal effect and osteogenic effect, and can safely form a firm physiological combination with bone tissue in a short period of time.
(2)人工关节表面钛酸钠生物活性涂层与金属基体结合强度高,并具有理想的微孔结构,可作为“晶核基面”促进磷灰石层的沉积生长,钛酸钠结构中的钠阳离子易于进行离子交换掺入各种元素,同时微孔也是BMP理想的载体,有利于BMP诱导成骨作用的充分发挥。(2) The sodium titanate bioactive coating on the surface of the artificial joint has high bonding strength with the metal matrix, and has an ideal microporous structure, which can be used as a "crystal nucleus base" to promote the deposition and growth of the apatite layer. In the sodium titanate structure The high sodium cations are easy to be ion-exchanged and incorporated into various elements, and the micropores are also ideal carriers for BMP, which is conducive to the full play of BMP-induced osteogenesis.
附图说明Description of drawings
图1为本发明人工关节表面具有微孔结构的钛酸钠表面层形态的扫描电镜(SEM)照片;Fig. 1 is the scanning electron microscope (SEM) photo of the sodium titanate surface layer morphology that artificial joint surface of the present invention has microporous structure;
图2是本发明人工关节表面具有微孔结构的钛酸钠表面层的X射线衍射(XRD)谱;Fig. 2 is the X-ray diffraction (XRD) spectrum of the sodium titanate surface layer with microporous structure on the artificial joint surface of the present invention;
具体实施方式Detailed ways
实施例1Example 1
(1)首先选用纯钛加工好人工关节;(1) First choose pure titanium to process the artificial joint;
(2)人工关节表面水热处理:将人工关节打磨抛光,然后用丙酮、70%的酒精、蒸馏水超声清洗,采用浓度为10mol/L的氢氧化钠水溶液进行水热反应,工作温度120摄氏度,处理时间为6小时,在人工关节表面获得具微孔结构的钛酸钠生物活性涂层。(2) Hydrothermal treatment of the artificial joint surface: the artificial joint is ground and polished, then ultrasonically cleaned with acetone, 70% alcohol, and distilled water, and the hydrothermal reaction is carried out with a sodium hydroxide aqueous solution with a concentration of 10mol/L, and the working temperature is 120 degrees Celsius. The time is 6 hours, and a sodium titanate bioactive coating with a microporous structure is obtained on the surface of the artificial joint.
(3)浸渍法掺铈处理:将上述制备的表面覆盖微孔钛酸钠生物活性层的人工关节浸渍在可溶性铈盐(NH4)2Ce(NO3)6水溶液中通过离子交换掺入稀土元素铈,(NH4)2Ce(NO3)6水溶液浓度为0.05mol·L-1,溶液液面应淹过人工关节,浸渍时间不少于24小时,随后用去离子水清洗几次,以消除剩余的可溶性离子(NH4 +,Ce4+,NO3 -),样品在真空下60-100℃干燥不少于6小时,以在人工关节表面获得铈掺杂的钛酸钠生物活性层;(3) Cerium doping treatment by dipping method: the artificial joint covered with microporous sodium titanate bioactive layer prepared above is immersed in soluble cerium salt (NH 4 ) 2 Ce(NO 3 ) 6 aqueous solution and doped with rare earth through ion exchange The element cerium, (NH 4 ) 2 Ce(NO 3 ) 6 aqueous solution concentration is 0.05mol·L -1 , the liquid surface of the solution should submerge the artificial joint, the immersion time is not less than 24 hours, and then washed several times with deionized water, In order to eliminate the remaining soluble ions (NH 4 + , Ce 4+ , NO 3 - ), the sample was dried under vacuum at 60-100°C for no less than 6 hours to obtain the biological activity of cerium-doped sodium titanate on the artificial joint surface layer;
(4)BMP的离心负载处理:将表面具微孔结构的掺铈钛酸钠生物活性涂层的人工关节固定于离心筒内,倒入0.1~50mg/L的骨形态发生蛋白和0.1mol/L的磷酸缓冲盐溶液组成的混合溶液,并淹过两倍以上高度,以6000rpm的离心速度工作时间5~30min,保持工作温度4~40℃,取出;(4) Centrifugal load treatment of BMP: fix the artificial joint with cerium-doped sodium titanate bioactive coating with microporous structure on the surface in the centrifuge cylinder, pour 0.1-50mg/L bone morphogenetic protein and 0.1mol/ A mixed solution composed of 1 L of phosphate buffered saline solution, and submerged to more than twice the height, worked at a centrifugal speed of 6000rpm for 5-30min, and kept at a working temperature of 4-40°C, then took it out;
(5)将上述取出人工关节用酒精淋洗后,真空干燥,消毒后无菌保存,备用,即可得本发明稀土元素铈缓释功能性的人工关节。(5) After taking out the above-mentioned artificial joint and rinsing it with alcohol, vacuum-dry it, store it aseptically after disinfection, and keep it for later use, the artificial joint with slow-release function of rare earth element cerium of the present invention can be obtained.
实施例2Example 2
(1)首先选用Ti6Al4V合金加工好人工关节;(1) First choose Ti6Al4V alloy to process the artificial joint;
(2)人工关节表面水热处理:将人工关节打磨抛光,然后用丙酮、70%的酒精、蒸馏水超声清洗,采用浓度为10mol/L的氢氧化钠水溶液进行水热反应,工作温度120摄氏度,处理时间为6小时,在人工关节表面获得具微孔结构的钛酸钠生物活性涂层。(2) Hydrothermal treatment of the artificial joint surface: the artificial joint is ground and polished, then ultrasonically cleaned with acetone, 70% alcohol, and distilled water, and the hydrothermal reaction is carried out with a sodium hydroxide aqueous solution with a concentration of 10mol/L, and the working temperature is 120 degrees Celsius. The time is 6 hours, and a sodium titanate bioactive coating with a microporous structure is obtained on the surface of the artificial joint.
(3)浸渍法掺铈处理:将上述制备的表面覆盖微孔钛酸钠生物活性层的人工关节浸渍在可溶性铈盐Ce(NO3)4水溶液中通过离子交换掺入稀土元素铈,Ce(NO3)4水溶液浓度为0.05mol·L-1,溶液液面应淹过人工关节,浸渍时间不少于24小时,随后用去离子水清洗几次,以消除剩余的可溶性离子(Ce4+,NO3 -),样品在真空下60-100℃干燥不少于6小时,以在人工关节表面获得铈掺杂的钛酸钠生物活性层;(3) Cerium doping treatment by dipping method: the artificial joint prepared above covered with the microporous sodium titanate bioactive layer was immersed in the soluble cerium salt Ce(NO 3 ) 4 aqueous solution, and the rare earth element cerium, Ce( The concentration of the NO 3 ) 4 aqueous solution is 0.05mol·L -1 , the liquid surface of the solution should be submerged over the artificial joint, the soaking time should not be less than 24 hours, and then washed several times with deionized water to eliminate the remaining soluble ions (Ce 4+ , NO 3 - ), the sample was dried under vacuum at 60-100°C for no less than 6 hours to obtain a bioactive layer of cerium-doped sodium titanate on the artificial joint surface;
(4)BMP的离心负载处理:将表面具微孔结构的掺铈钛酸钠生物活性涂层的人工关节固定于离心筒内,倒入0.1~50mg/L的骨形态发生蛋白和0.1mol/L的磷酸缓冲盐溶液组成的混合溶液,并淹过两倍以上高度,以8000rpm的离心速度工作时间5~30min,保持工作温度4~40℃,取出;(4) Centrifugal load treatment of BMP: fix the artificial joint with cerium-doped sodium titanate bioactive coating with microporous structure on the surface in the centrifuge cylinder, pour 0.1-50mg/L bone morphogenetic protein and 0.1mol/ A mixed solution composed of 1 L of phosphate buffered saline solution, and submerged to more than twice the height, worked at a centrifugal speed of 8000rpm for 5-30min, and kept the working temperature at 4-40°C, and took it out;
(5)将上述取出人工关节用酒精淋洗后,真空干燥,消毒后无菌保存,备用,即可得本发明稀土元素铈缓释功能性的人工关节。(5) After taking out the above-mentioned artificial joint and rinsing it with alcohol, vacuum-dry it, store it aseptically after disinfection, and keep it for later use, the artificial joint with slow-release function of rare earth element cerium of the present invention can be obtained.
实施例3Example 3
(1)首先选用纯钛加工好人工关节;(1) First choose pure titanium to process the artificial joint;
(2)人工关节表面水热处理:将人工关节打磨抛光,然后用丙酮、70%的酒精、蒸馏水超声清洗,采用浓度为10mol/L的氢氧化钠水溶液进行水热反应,工作温度150摄氏度,处理时间为72小时,在人工关节表面获得具微孔结构的钛酸钠生物活性涂层,其SEM照片和XRD谱分别见图1和图2。(2) Hydrothermal treatment of the artificial joint surface: the artificial joint is ground and polished, then ultrasonically cleaned with acetone, 70% alcohol, and distilled water, and the hydrothermal reaction is carried out with a sodium hydroxide aqueous solution with a concentration of 10mol/L, and the working temperature is 150 degrees Celsius. After 72 hours, a sodium titanate bioactive coating with a microporous structure was obtained on the surface of the artificial joint, and its SEM photo and XRD spectrum are shown in Figure 1 and Figure 2, respectively.
(3)浸渍法掺铈处理:将上述制备的表面覆盖微孔钛酸钠生物活性层的人工关节浸渍在可溶性铈盐(NH4)2Ce(NO3)6水溶液中通过离子交换掺入稀土元素铈,(NH4)2Ce(NO3)6水溶液浓度为0.05mol·L-1,溶液液面应淹过人工关节,浸渍时间不少于24小时,随后用去离子水清洗几次,以消除剩余的可溶性离子(NH4 +,Ce4+,NO3 -),样品在真空下60-100℃干燥不少于6小时,以在人工关节表面获得铈掺杂的钛酸钠生物活性层;(3) Cerium doping treatment by dipping method: the artificial joint covered with microporous sodium titanate bioactive layer prepared above is immersed in soluble cerium salt (NH 4 ) 2 Ce(NO 3 ) 6 aqueous solution and doped with rare earth through ion exchange The element cerium, (NH 4 ) 2 Ce(NO 3 ) 6 aqueous solution concentration is 0.05mol·L -1 , the liquid surface of the solution should submerge the artificial joint, the immersion time is not less than 24 hours, and then washed several times with deionized water, In order to eliminate the remaining soluble ions (NH 4 + , Ce 4+ , NO 3 - ), the sample was dried under vacuum at 60-100°C for no less than 6 hours to obtain the biological activity of cerium-doped sodium titanate on the artificial joint surface layer;
(4)BMP的离心负载处理:将表面具微孔结构的掺铈钛酸钠生物活性涂层的人工关节固定于离心筒内,倒入0.1~50mg/L的骨形态发生蛋白和0.1mol/L的磷酸缓冲盐溶液组成的混合溶液,并淹过两倍以上高度,以6000rpm的离心速度工作时间5~30min,保持工作温度4~40℃,取出;(4) Centrifugal load treatment of BMP: fix the artificial joint with cerium-doped sodium titanate bioactive coating with microporous structure on the surface in the centrifuge cylinder, pour 0.1-50mg/L bone morphogenetic protein and 0.1mol/ A mixed solution composed of 1 L of phosphate buffered saline solution, and submerged to more than twice the height, worked at a centrifugal speed of 6000rpm for 5-30min, and kept at a working temperature of 4-40°C, then took it out;
(5)将上述取出人工关节用酒精淋洗后,真空干燥,消毒后无菌保存,备用,即可得本发明稀土元素铈缓释功能性的人工关节。(5) After taking out the above-mentioned artificial joint and rinsing it with alcohol, vacuum-dry it, store it aseptically after disinfection, and keep it for later use, the artificial joint with slow-release function of rare earth element cerium of the present invention can be obtained.
实施例4Example 4
(1)首先选用Ti6Al4V合金加工好人工关节;(1) First choose Ti6Al4V alloy to process the artificial joint;
(2)人工关节表面水热处理:将人工关节打磨抛光,然后用丙酮、70%的酒精、蒸馏水超声清洗,采用浓度为10mol/L的氢氧化钠水溶液进行水热反应,工作温度150摄氏度,处理时间为72小时。(2) Hydrothermal treatment of the artificial joint surface: the artificial joint is ground and polished, then ultrasonically cleaned with acetone, 70% alcohol, and distilled water, and the hydrothermal reaction is carried out with a sodium hydroxide aqueous solution with a concentration of 10mol/L, and the working temperature is 150 degrees Celsius. The time is 72 hours.
(3)浸渍法掺铈处理:将上述制备的表面覆盖微孔钛酸钠生物活性层的人工关节浸渍在可溶性铈盐CeCl4水溶液中通过离子交换掺入稀土元素铈,CeCl4水溶液浓度为0.05mol·L-1,溶液液面应淹过人工关节,浸渍时间不少于24小时,随后用去离子水清洗几次,以消除剩余的可溶性离子(Ce4+,Cl-),样品在真空下60-100℃干燥不少于6小时,以在人工关节表面获得铈掺杂的钛酸钠生物活性层;(3) Cerium doping treatment by dipping method: the artificial joint prepared above covered with microporous sodium titanate bioactive layer is immersed in soluble cerium salt CeCl 4 aqueous solution and doped with rare earth element cerium by ion exchange, the concentration of CeCl 4 aqueous solution is 0.05 mol·L -1 , the liquid level of the solution should cover the artificial joint, the soaking time should not be less than 24 hours, and then wash several times with deionized water to eliminate the remaining soluble ions (Ce 4+ , Cl - ), the sample is vacuum Dry at 60-100°C for no less than 6 hours to obtain a bioactive layer of cerium-doped sodium titanate on the surface of the artificial joint;
(4)BMP的离心负载处理:将表面具微孔结构的掺铈钛酸钠生物活性涂层的人工关节固定于离心筒内,倒入0.1~50mg/L的骨形态发生蛋白和0.1mol/L的磷酸缓冲盐溶液组成的混合溶液,并淹过两倍以上高度,以80000rpm的离心速度工作时间5~30min,保持工作温度4~40℃,取出;(4) Centrifugal load treatment of BMP: fix the artificial joint with cerium-doped sodium titanate bioactive coating with microporous structure on the surface in the centrifuge cylinder, pour 0.1-50mg/L bone morphogenetic protein and 0.1mol/ A mixed solution composed of 1 L of phosphate buffered saline solution, and submerged to more than twice the height, worked at a centrifugal speed of 80,000rpm for 5-30min, and kept at a working temperature of 4-40°C, then took it out;
(5)将上述取出人工关节用酒精淋洗后,真空干燥,消毒后无菌保存,备用,即可得本发明稀土元素铈缓释功能性的人工关节。(5) After taking out the above-mentioned artificial joint and rinsing it with alcohol, vacuum-dry it, store it aseptically after disinfection, and keep it for later use, the artificial joint with slow-release function of rare earth element cerium of the present invention can be obtained.
显然,本发明的上述实施例仅仅是为了清楚说明本发明所作的举例,而并非是对本发明的实施方式的限定。对于所属领域的普通技术人员来说,还可在上述说明的基础上做出其它不同形式的变化或变动,这里无需也无法对所有实施方式予以穷举,而这些属于本发明的精神所引申出的显而易见的变化或变动仍处于本发明的保护范围内。Apparently, the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, rather than limiting the implementation of the present invention. For those of ordinary skill in the art, other different forms of changes or changes can also be made on the basis of the above description, and it is not necessary and impossible to exhaustively enumerate all the implementation modes here, and these are derived from the spirit of the present invention. Obvious changes or modifications are still within the protection scope of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010017102A CN101766841B (en) | 2010-01-01 | 2010-01-01 | Artificial joint having slow-release function of rare earth element cerium and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010017102A CN101766841B (en) | 2010-01-01 | 2010-01-01 | Artificial joint having slow-release function of rare earth element cerium and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101766841A true CN101766841A (en) | 2010-07-07 |
CN101766841B CN101766841B (en) | 2012-10-24 |
Family
ID=42500041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010017102A Expired - Fee Related CN101766841B (en) | 2010-01-01 | 2010-01-01 | Artificial joint having slow-release function of rare earth element cerium and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101766841B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007347A (en) * | 2012-11-26 | 2013-04-03 | 上海交通大学 | A method of loading gentamicin by in-situ synthesis of TiO2 nanotube coating on Ti surface |
CN114432499A (en) * | 2021-12-20 | 2022-05-06 | 脉通医疗科技(嘉兴)有限公司 | Artificial blood vessel and preparation method thereof |
CN114470326A (en) * | 2021-12-06 | 2022-05-13 | 中国人民解放军空军军医大学 | A kind of biomimetic mineralized collagen-glycosaminoglycan material preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE517365C2 (en) * | 1998-03-19 | 2002-05-28 | Biomat System Ab | Ceramic silica nitride biomaterial and method for its manufacture |
CN1234427C (en) * | 2004-01-16 | 2006-01-04 | 东南大学 | Bioactivity artificial joint material and preparation method thereof |
-
2010
- 2010-01-01 CN CN201010017102A patent/CN101766841B/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007347A (en) * | 2012-11-26 | 2013-04-03 | 上海交通大学 | A method of loading gentamicin by in-situ synthesis of TiO2 nanotube coating on Ti surface |
CN103007347B (en) * | 2012-11-26 | 2014-12-10 | 上海交通大学 | A method of loading gentamicin by in-situ synthesis of TiO2 nanotube coating on Ti surface |
CN114470326A (en) * | 2021-12-06 | 2022-05-13 | 中国人民解放军空军军医大学 | A kind of biomimetic mineralized collagen-glycosaminoglycan material preparation method and application thereof |
CN114470326B (en) * | 2021-12-06 | 2022-09-13 | 中国人民解放军空军军医大学 | Preparation method and application of biomimetic mineralized collagen-glycosaminoglycan material |
CN114432499A (en) * | 2021-12-20 | 2022-05-06 | 脉通医疗科技(嘉兴)有限公司 | Artificial blood vessel and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101766841B (en) | 2012-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766839B (en) | Silver-loaded antibacterial artificial joint and preparation method thereof | |
CN104032291B (en) | One prepares TiSrO at titanium implant surface3The method of coating | |
CN107661544B (en) | Antibacterial and osteopromoting composite functional porous orthopedic implant and preparation method thereof | |
CN101766840B (en) | Antibacterial functionalized artificial joint with silver-loaded nanotube array surface | |
CN101766540A (en) | Antibacterial artificial tooth root with bioactivity and preparation method thereof | |
CN101766541B (en) | Antimicrobial artificial tooth root based on nanometer tube arrays and preparation method thereof | |
CN101745146B (en) | Functional artificial joint on surface of cerium-loaded nanotube array and preparation method thereof | |
CN104846371B (en) | A kind of method for preparing molecular sieve coating in medical magnesium alloy surface | |
CN101732762B (en) | Bioactive artificial joint capable of slowly releasing trace element selenium | |
CN101732761B (en) | Joint prosthesis by using titanium oxide nanotubes to load bone morphogenetic protein | |
CN101766841B (en) | Artificial joint having slow-release function of rare earth element cerium and preparation method thereof | |
CN1234427C (en) | Bioactivity artificial joint material and preparation method thereof | |
CN104532213B (en) | Preparation method of medical implant material surface function atom doped molecular sieve layer | |
CN108744047A (en) | A kind of preparation method of titanium nanometer/fibroin albumen/hydroxyapatite composite medical titanium coating | |
CN101791267B (en) | Bioactive artificial tooth root capable of slowly releasing rare earth element cerium | |
CN101744666B (en) | Artificial tooth root with trace element selenium sustained-release function and preparation method thereof | |
CN101766838B (en) | Functionalized artificial joint with selenium-loaded nanotube array surface and preparation method thereof | |
CN106498397A (en) | A kind of method in titanio implant surface in-situ construction multi-stage nano topological structure that is lost based on salt | |
CN101766538B (en) | Rare earth element cerium slow-release artificial tooth root based on nanotube array surface | |
CN108434523A (en) | A kind of preparation method of strontium doping hydroxyapatite laminated film | |
CN102266584A (en) | Medical porous titanium-containing material/surface molecular sieve coating material and preparation method thereof | |
CN118653193A (en) | Method for preparing zinc-containing antibacterial coating on the surface of medical implant material | |
CN104195531B (en) | A kind of method at hot-dipping galvanized coating surface biomimetic deposited hydroxyl apatite | |
CN103896629B (en) | A kind of surface treatment method of silicon doping Ca-P ceramic | |
CN115671392A (en) | A kind of strong artificial bone material with osteogenic active coating and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG MINGXIN CHEMICALS CO., LTD. Free format text: FORMER OWNER: SOWTHEAST UNIV. Effective date: 20131021 Owner name: SOWTHEAST UNIV. Effective date: 20131021 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210096 NANJING, JIANGSU PROVINCE TO: 226600 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131021 Address after: 5 groups of Huang Chen Cun Nan Mo Haian County town of 226600 Jiangsu city of Nantong Province Patentee after: NANTONG MINGXIN CHEMICALS Co.,Ltd. Patentee after: SOUTHEAST University Address before: 210096 Jiangsu city Nanjing Province four pailou No. 2 Patentee before: Southeast University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121024 |
|
CF01 | Termination of patent right due to non-payment of annual fee |